Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Spiroindane Cyclopentadiene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115093313A discloses high-enantioselectivity rhodium catalysts for C-H activation, offering scalable routes for pharmaceutical intermediates.